Dealing with red, itchy eyelids? The culprit could be a common mite. This article is sponsored by XDEMVY. Dr. Watson is a ...

Groundbreaking data from the Ersa and Rhea clinical trials for the treatment of Demodex blepharitis (DB) in patients with Meibomian Gland Disease (MGD) further underscore the utility of XDEMVY broadly ...

Combined ivermectin and intense pulsed light therapy can help resolve Demodex blepharitis and prevent its recurrence.

This follows a successful 2024 for Tarsus, highlighted by the strong launch of XDEMVY, a treatment for Demodex blepharitis, generating over $113 million in sales. Tarsus is also pursuing ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

Tarsus Pharmaceuticals, which has more than 100 of its 331 employees in Orange County, has plans to double its office space ...

Historically, patients with Demodex blepharitis simply had to "deal with ... Tarsus Pharmaceuticals is also on a treatment for rosacea around the eyes and a drug that could prevent Lyme disease.